These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 17097366)

  • 1. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.
    Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J;
    J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychophysical aspects of hidradenitis suppurativa.
    Matusiak L; Bieniek A; Szepietowski JC
    Acta Derm Venereol; 2010 May; 90(3):264-8. PubMed ID: 20526543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
    Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
    Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants.
    Oostenbrink R; Spong K; de Goede-Bolder A; Landgraf JM; Raat H; Moll HA
    J Pediatr; 2007 Aug; 151(2):182-6, 186.e1-2. PubMed ID: 17643775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychosocial impact of hidradenitis suppurativa.
    Gooderham M; Papp K
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S19-22. PubMed ID: 26470609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.
    Sartorius K; Emtestam L; Jemec GB; Lapins J
    Br J Dermatol; 2009 Oct; 161(4):831-9. PubMed ID: 19438453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported skin morbidities and health-related quality of life: a population-based nested case-control study.
    Vinding GR; Knudsen KM; Ellervik C; Olesen AB; Jemec GB
    Dermatology; 2014; 228(3):261-8. PubMed ID: 24642860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial impact of hidradenitis suppurativa: a qualitative study.
    Esmann S; Jemec GB
    Acta Derm Venereol; 2011 May; 91(3):328-32. PubMed ID: 21394419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.
    Revuz JE; Canoui-Poitrine F; Wolkenstein P; Viallette C; Gabison G; Pouget F; Poli F; Faye O; Roujeau JC; Bonnelye G; Grob JJ; Bastuji-Garin S
    J Am Acad Dermatol; 2008 Oct; 59(4):596-601. PubMed ID: 18674845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis suppurativa markedly decreases quality of life and professional activity.
    Matusiak Ł; Bieniek A; Szepietowski JC
    J Am Acad Dermatol; 2010 Apr; 62(4):706-8, 708.e1. PubMed ID: 20227585
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
    Esmann S; Dufour DN; Jemec GB
    Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does incontinence severity correlate with quality of life? Prospective analysis of 502 consecutive patients.
    Bordeianou L; Rockwood T; Baxter N; Lowry A; Mellgren A; Parker S
    Colorectal Dis; 2008 Mar; 10(3):273-9. PubMed ID: 17608751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients.
    Fardet L; Dupuy A; Kerob D; Levy A; Allez M; Begon E; Bachelez H; Morel P; Lebbé C
    J Am Acad Dermatol; 2007 Apr; 56(4):624-8. PubMed ID: 17240478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of hidradenitis suppurativa in Denmark].
    Jemec GB; Heidenheim M; Nielsen NH
    Ugeskr Laeger; 1998 Feb; 160(6):847-9. PubMed ID: 9469984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perception of head and neck cancer quality of life within the medical world: a multicultural study.
    Demez PH; Moreau PR
    Head Neck; 2009 Aug; 31(8):1056-67. PubMed ID: 19340871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients with hidradenitis suppurativa.
    Ball SL; Tidman MJ
    Practitioner; 2016 May; 260(1793):25-9, 3. PubMed ID: 27382916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa: A growing concern.
    Jemec GB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S3. PubMed ID: 26470612
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.